
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.320 | 1.320 | 0.000 |
Shares | 98.680 | 98.680 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.992 | 19.703 |
Price to Book | 2.515 | 3.888 |
Price to Sales | 2.469 | 2.230 |
Price to Cash Flow | 14.279 | 14.908 |
Dividend Yield | 0.369 | 1.492 |
5 Years Earnings Growth | 15.829 | 10.156 |
Number of long holdings: 34
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Swedish Orphan Biovitrum | SE0000872095 | 8.92 | 264.40 | -1.93% | |
UCB | BE0003739530 | 8.01 | 184.85 | -2.94% | |
Zealand Pharma | DK0060257814 | 5.61 | 327.50 | -4.71% | |
Argen-X | NL0010832176 | 5.49 | 584.20 | -1.72% | |
Fresenius SE | DE0005785604 | 4.84 | 41.090 | -2.12% | |
Asker Healthcare AB | SE0024171458 | 3.83 | 96.61 | -3.66% | |
Uniphar | IE00BJ5FQX74 | 3.73 | 3.85 | -3.75% | |
H Lundbeck B | DK0061804770 | 3.55 | 33.66 | -2.26% | |
Hikma Pharma | GB00B0LCW083 | 3.35 | 1,939.00 | -1.27% | |
Merus | NL0011606264 | 3.33 | 65.56 | -1.03% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Technology Fund | 8.31B | 17.39 | 29.43 | 19.08 | ||
Global Technology Fund I | 8.31B | 17.69 | 30.09 | 19.61 | ||
Global Technology Fund R | 8.31B | 17.39 | 29.44 | 19.09 | ||
IE00BFMFD979 | 3.35B | 7.08 | -5.04 | - | ||
IE00BJ205H20 | 3.35B | 6.77 | -5.27 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review